迦南科技(300412.SZ):迦南集團累計減持1291.5萬股
格隆匯12月9日丨迦南科技(300412.SZ)公佈,公司於近日收到控股股東迦南科技集團有限公司(“迦南集團”)出具的減持完畢告知函和《簡式權益變動報告書》,迦南集團於2019年12月5日、12月6日及12月9日合計減持254.5萬股,其減持計劃已完成;同時自2018年11月27日至2019年12月9日期間,迦南集團通過深圳證券交易所集中競價和大宗交易方式累計減持公司股份合計1291.5萬股,佔公司總股本的5%。
此次減持後,迦南集團持股比例由31.36%降至26.36%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.